secwatch / observer
8-K filed May 16, 2023, 7:59 PM ET ticker BDTX CIK 0001701541
other material confidence high sentiment neutral materiality 0.15

Black Diamond Therapeutics elects three Class III directors, ratifies auditor at annual meeting

Black Diamond Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Black Diamond Therapeutics, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2023 at the 2023-05-16 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-16
Exact text from the filing
Proposal No. 2 The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. The results of the ratification were as follows: FOR AGAINST ABSTAIN 31,012,770 22,331 17,856
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Black Diamond Therapeutics, Inc. shareholders approved Election of three Class III director nominees at the 2023-05-16 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-16
Exact text from the filing
Proposal No. 1 David M. Epstein, Wendy L. Dixon and Kapil Dhingra were duly elected to the Board as Class III directors. The results of the election were as follows: CLASS II DIRECTOR NOMINEE FOR WITHHELD BROKER NON- VOTES David M. Epstein 26,357,348 84,077 4,611,532 Wendy L. Dixon 19,131,310 7,310,115 4,611,532 Kapil Dhingra 20,012,773 6,428,652 4,611,532
View on SEC.gov

Browse all shareholder votes →

Black Diamond Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-061486
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.